| NCT ID | NCT06540521 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Medtronic Cardiac Rhythm and Heart Failure |
| Condition | Heart Failure |
| Study Type | OBSERVATIONAL |
| Enrollment | 75 participants |
| Start Date | 2024-08-13 |
| Primary Completion | 2026-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 75 participants in total. It began in 2024-08-13 with a primary completion date of 2026-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to investigate the cardiac electrical characteristics in different pacing outputs and body positions in LBB area pacing (LBBAP), from which the findings may help to develop and support data validation of a novel algorithm for LBB capture determination for LBBAP.
Eligibility Criteria
Inclusion Criteria: * Patients aged \>=18 years * Patients who are willing to provide Informed Consent * Patients who have received LBBAP therapy \>= 1 month for 1 to 4 months (including 1 and 4 month) * Patients implanted with a single/dual-chamber pacemaker or a CRT-P with LBBAP lead connected to RV port * Implanted device can provide at least 3-channel real-time intracardiac electrogram Exclusion Criteria: * Patients who are pregnant or have a plan for pregnancy during the study * Patients who have medical conditions that would limit study participation * Patients who were already enrolled in clinical trial(s) which would impact study participation
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06540521 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Heart Failure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06540521 currently recruiting?
Yes, NCT06540521 is actively recruiting participants. Contact the research team at Simon.cao@medtronic.com for enrollment information.
Where is the NCT06540521 trial being conducted?
This trial is being conducted at Shanghai, China, Hangzhou, China.
Who is sponsoring the NCT06540521 clinical trial?
NCT06540521 is sponsored by Medtronic Cardiac Rhythm and Heart Failure. The trial plans to enroll 75 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.